Teva Pharmaceutical Industries (TEVA) Consolidated Net Income (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) posted Consolidated Net Income of $234 million for Q3 2026, down 46.1% from $434 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Consolidated Net Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Consolidated Net Income at Teva Pharmaceutical Industries was $509 million, down 23.1% year-over-year; for FY2025, it came in at $1.42 billion.
- In prior years, Teva Pharmaceutical Industries' Consolidated Net Income was -$1.96 billion in FY2024, -$615 million in FY2023, -$2.5 billion in FY2022 and $456 million in FY2021.
- Quarterly Consolidated Net Income has run from a low of -$1.33 billion in Q4 2022 to a high of $481 million in Q4 2025 over five years.
- According to Business Quant data, Consolidated Net Income for the three prior quarters was -$575 million (Q2 2026), $369 million (Q1 2026) and $481 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Teva Pharmaceutical Industries | 49.58 Bn | 34.55 Bn | 2.44 Bn | 234.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 234.00 Mn |
| Jun 30, 2026 | -575.00 Mn |
| Mar 31, 2026 | 369.00 Mn |
| Dec 31, 2025 | 481.00 Mn |
| Sep 30, 2025 | 434.00 Mn |
| Jun 30, 2025 | 283.00 Mn |
| Mar 31, 2025 | 220.00 Mn |
| Dec 31, 2024 | -275.00 Mn |
| Sep 30, 2024 | -390.00 Mn |
| Jun 30, 2024 | -874.00 Mn |
| Mar 31, 2024 | -419.00 Mn |
| Dec 31, 2023 | 467.00 Mn |
| Sep 30, 2023 | 77.00 Mn |
| Jun 30, 2023 | -906.00 Mn |
| Mar 31, 2023 | -253.00 Mn |
| Dec 31, 2022 | -1.33 Bn |
| Sep 30, 2022 | 63.00 Mn |
| Jun 30, 2022 | -278.00 Mn |
| Mar 31, 2022 | -952.00 Mn |
| Dec 31, 2021 | -152.00 Mn |
API Access
Teva Pharmaceutical Industries Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();